Skip to main content

CDT Equity Inc.

corporate_fare Company Profile

CDT Equity Inc.

CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed CDT - Latest Insights

CDT
Apr 21, 2026, 9:56 PM EDT
Filing Type: S-3
Importance Score:
9
CDT
Apr 15, 2026, 5:01 PM EDT
Filing Type: 10-K
Importance Score:
9
CDT
Apr 02, 2026, 4:15 PM EDT
Filing Type: 424B5
Importance Score:
9
CDT
Mar 30, 2026, 9:21 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
CDT
Mar 26, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
CDT
Mar 25, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
8
CDT
Mar 18, 2026, 4:53 PM EDT
Filing Type: 8-K
Importance Score:
9
CDT
Mar 18, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
9
CDT
Mar 09, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
CDT
Mar 06, 2026, 4:12 PM EST
Filing Type: DEF 14A
Importance Score:
10
CDT
Feb 24, 2026, 5:11 PM EST
Filing Type: 8-K
Importance Score:
9
CDT
Feb 24, 2026, 4:53 PM EST
Filing Type: PRE 14A
Importance Score:
10
CDT
Feb 10, 2026, 4:20 PM EST
Filing Type: 424B3
Importance Score:
9
CDT
Jan 29, 2026, 7:26 PM EST
Filing Type: S-3
Importance Score:
9
CDT
Jan 22, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
9
CDT
Jan 02, 2026, 4:32 PM EST
Filing Type: 8-K
Importance Score:
7